Synthesis and preparation of biocompatible and pH-responsive cyclodextrin-based nanoparticle
Source abstract
Abstract
As a temporarily protective reaction for active hydrogen group, acetylation is reversible and responsive to low pH value. According to the reaction, pH-sensitive β-cyclodextrin (β-CD) was synthesized in the first step of our research. During the synthesis, the acetal groups including linear acetal (LA) groups and cyclic acetal (CA) groups were successfully modified onto β-CD. Particularly, the structural details of acetalated β-CD (Ac-β-CD) were greatly influenced by reaction time. Furthermore, in respect to water solubility, Ac-β-CDs exhibited different pH response properties due to their different structure. In the second step, Ac-β-CD1 nanoparticles were prepared by a single oil-in-water (O/W) emulsion technique using a biocompatible emulsifier, gelatin. Meanwhile, gelatin was absorbed onto the surface of nanoparticle, which was confirmed by FTIR spectra. The formed nanoparticles showed monodispersion and nearly spherical morphology. In order to obtain optimal preparing conditions, the effects of preparative parameters such as gelatin concentration, Ac-β-CD concentration, and water/oil ratio on properties including diameters and zeta potential as well as gelatin content were investigated. Moreover, the pH response properties of nanoparticle were characterized by transparency of nanoparticle solution. Finally, in vitro cell culture confirmed that Ac-β-CD nanoparticle could support cell survival and enhance cell viability.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Membrane Separation Technologies · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Bachelder EM, Beaudette TT, Broaders KE, Frechet JM, Albrecht MT, Mateczun AJ, Ainslie KM, Pesce JT, Keane-Myers AM (2010) In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol Pharm 7(3):826–83510.1021/mp900311x ↗
2. Bai H, Li C, Wang X, Shi G (2010) A pH-sensitive graphene oxide composite hydrogel. Chem Commun (Camb) 46(14):2376–237810.1039/c000051e ↗
3. Batta K, Das C, Gadad S, Shandilya J, Kundu TK (2007) Reversible acetylation of non histone proteins: role in cellular function and disease. Subcell Biochem 41:193–21210.1007/1-4020-5466-1_9 ↗
4. Borteh HM, Gallovic MD, Sharma S, Peine KJ, Miao S, Brackman DJ, Gregg K, Xu Y, Guo X, Guan J, Bachelder EM, Ainslie KM (2013) Electrospun acetalated dextran scaffolds for temporal release of therapeutics. Langmuir 29(25):7957–796510.1021/la400541e ↗
5. Broaders KE, Cohen JA, Beaudette TT, Bachelder EM, Frechet JM (2009) Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. Proc Natl Acad Sci U S A 106(14):5497–550210.1073/pnas.0901592106 ↗
6. Chen H, Liu X, Dou Y, He B, Liu L, Wei Z, Li J, Wang C, Mao C, Zhang J, Wang G (2013) A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials 34(16):4159–417210.1016/j.biomaterials.2013.02.035 ↗
7. Cohen T, Yao TP (2004) AcK-knowledge reversible acetylation. Sci STKE 2004(245):pe4210.1126/stke.2452004pe42 ↗
8. Concheiro A, Alvarez-Lorenzo C (2013) Chemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devices. Adv Drug Deliv Rev 65:1188–120310.1016/j.addr.2013.04.015 ↗
9. Fojo AT, Whitney PL, Awad WM (1983) Effects of acetylation and guanidination on alkaline conformations of chymotrypsin. Arch Biochem Biophys 224(2):636–64210.1016/0003-9861(83)90251-5 ↗
10. Ganta S, Devalapally H, Shahiwala A, Amiji M (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 126(3):187–20410.1016/j.jconrel.2007.12.017 ↗
11. Hayden JD, Brown LR, Gunawardena HP, Perkowski EF, Chen X, Braunstein M (2013) Reversible acetylation regulates acetate and propionate metabolism in Mycobacterium smegmatis. Microbiology 159(Pt 9):1986–199910.1099/mic.0.068585-0 ↗
12. He H, Chen S, Zhou J, Dou Y, Song L, Chen L, Zhou X, Chen X, Jia Y, Zhang J, Li S, Li X (2013) Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel. Biomaterials 34(21):5344–535810.1016/j.biomaterials.2013.03.068 ↗
13. Hirata H, Kawanishi M, Iwata Y, Sakaki K, Yanagishita H (2007) Kinetic studies on lipase-catalyzed acetylation of 2-alkanol with vinyl acetate in organic solvent. J Oleo Sci 56(6):309–31710.5650/jos.56.309 ↗
14. Hoang KV, Borteh HM, Rajaram MV, Peine KJ, Curry H, Collier MA, Homsy ML, Bachelder EM, Gunn JS, Schlesinger LS, Ainslie KM (2014) Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection. Int J Pharm 477(1–2):334–34310.1016/j.ijpharm.2014.10.022 ↗
15. Hu XH, Gong X (2016) A new route to fabricate biocompatible hydrogels with controlled drug delivery behavior. J Colloid Interface Sci 470:62–7010.1016/j.jcis.2016.02.037 ↗
16. Hu XH, Tan HT, Wang X, Chen P (2016) Surface functionalization of hydrogel by thiol-yne click chemistry for drug delivery. Colloids and Surfaces A: Physicochem. Eng. Aspects 489:297–30410.1016/j.colsurfa.2015.11.007 ↗
17. Jeninga EH, Schoonjans K, Auwerx J (2010) Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility. Oncogene 29(33):4617–462410.1038/onc.2010.206 ↗
18. Kauffman KJ, Do C, Sharma S, Gallovic MD, Bachelder EM, Ainslie KM (2012) Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product. ACS Appl Mater Interfaces 4(8):4149–415510.1021/am3008888 ↗
19. Kluger R, Tsui WC (1986) Reaction of the anionic acetylation agent methyl acetyl phosphate with D-3-hydroxybutyrate dehydrogenase. Biochem Cell Biol 64(5):434–44010.1139/o86-061 ↗
20. Li X, Wu M, Pan L, Shi J (2016) Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor. Int J Nanomedicine 11:93–105
21. Maksimov IV, Valeev A, Safin RF (2011) Acetylation degree of chitin in the protective response of wheat plants. Biochemistry (Mosc) 76(12):1342–134610.1134/S0006297911120078 ↗
22. Meenach SA, Kim YJ, Kauffman KJ, Kanthamneni N, Bachelder EM, Ainslie KM (2012) Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery. Mol Pharm 9(2):290–29810.1021/mp2003785 ↗
23. Mundra V, Li W, Mahato RI (2015) Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (Lond) 10(16):2613–263310.2217/nnm.15.111 ↗
24. Nguyen BD, Xia Z, Cutruzzola F, Allocatelli CT, Brunori M, LaMar GN (2000) Solution (1)H NMR study of the influence of distal hydrogen bonding and N terminus acetylation on the active site electronic and molecular structure of Aplysia limacina cyanomet myoglobin. J Biol Chem 275(2):742–75110.1074/jbc.275.2.742 ↗
25. Schully KL, Sharma S, Peine KJ, Pesce J, Elberson MA, Fonseca ME, Prouty AM, Bell MG, Borteh H, Gallovic M, Bachelder EM, Keane-Myers A, Ainslie KM (2013) Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis. Pharm Res 30(5):1349–136110.1007/s11095-013-0975-x ↗
26. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A 103(27):10224–1022910.1073/pnas.0603968103 ↗
27. Shi Q, Zhang L, Liu M, Zhang X, Xu X, Chen S, Li X, Zhang J (2015) Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells. Biomaterials 67:169–18210.1016/j.biomaterials.2015.07.023 ↗
28. Suarez S, Grover GN, Braden RL, Christman KL, Almutairi A (2013) Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI. Biomacromolecules 14(11):3927–393510.1021/bm401050j ↗
29. Tan HP, Marra KG (2010) Injectable, biodegradable hydrogels for tissue engineering applications. Materials 3(3):1746–176710.3390/ma3031746 ↗
30. Tyagi P, Wu PC, Chancellor M, Yoshimura N, Huang L (2006) Recent advances in intravesical drug/gene delivery. Mol Pharm 3(4):369–37910.1021/mp060001j ↗